We recently published an article titled, Jim Cramer’s Latest Lightning Round: 12 Stocks to Watch. In this article, we are ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

On Thursday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $188.57 which represents a decrease of $-1.89 or -0.99% from the prior close of $190.46. The stock opened at $190.54 and touched a ...

AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.55, payable on Tuesday Oct.

Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor ...

It is expected to release its Q3 earnings before the market opens on Wednesday, Oct. 30. Ahead of the event, analysts expect ...

Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.

AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.

IQ EQ FUND MANAGEMENT IRELAND Ltd lessened its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.0% during the ...

AbbVie Inc.'s top executives and board members dodged a shareholder derivative suit related to the pharmaceutical company’s ...

Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Automatic Data ...

On Friday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $194.19 which represents a decrease of $-0.16 or -0.08% from the prior close of $194.35. The stock opened at $195 and touched a low ...